These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9382555)

  • 1. [Correlation between anti-tumor effects and serum hepatocyte growth factor level in patients with liver metastases from gastric cancer treated by induced hypertensive chemotherapy with angiotensin II].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1874-7. PubMed ID: 9382555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induced hypertensive chemotherapy with angiotensin-II for liver metastases from gastric cancer].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1558-60. PubMed ID: 8854804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer].
    Ohashi M; Arai K; Iwasaki Y; Takahashi T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1777-80. PubMed ID: 10560393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrahepatic arterial infusion chemotherapy with angiotensin II for liver metastasis from gastric cancer].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1412-5. PubMed ID: 9703841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of hepatocyte growth factor in breast cancer patients.
    Taniguchi T; Toi M; Inada K; Imazawa T; Yamamoto Y; Tominaga T
    Clin Cancer Res; 1995 Sep; 1(9):1031-4. PubMed ID: 9816076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapeutic effect on metastatic tumors].
    Takahashi H; Sato H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1255-9. PubMed ID: 2499264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
    Imamura Y; Yasutake K; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Ohno S; Masuda T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1501-7. PubMed ID: 2143888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and intra-arterial chemotherapy response of liver metastases.
    Hanazaki K; Kawamura N; Sodeyama H; Wakabayashi M; Yokoyama S; Sode Y; Miyazaki T; Okazaki Y
    Hepatogastroenterology; 1998; 45(20):462-7. PubMed ID: 9638428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
    Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between effectiveness of hepatic artery injection chemotherapy and serum VEGF].
    Okada N; Ishida H; Takeuchi I; Yokoyama M; Nakata H; Hashimoto D; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1639-42. PubMed ID: 14619483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.